Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

2013141 citationsletter

Authors

Sally Arai · Stanford University

Michelle A. Fanale · The University of Texas MD Anderson Cancer Center

Sven deVos · University of California, Los Angeles

Andreas Engert · German Inflammatory Bowel Diseases Study Group

Tim Illidge · University of Manchester

Peter Borchmann · German Inflammatory Bowel Diseases Study Group

Anas Younes

Abstract

Primary therapy for Hodgkin lymphoma (HL) is curative in ˜ 85% of patients [1]. Randomized phase III and single arm phase II trials have established high dose chemotherapy and autologous hematopoie...

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Leukemia & lymphoma/Leukemia and lymphoma

Volume 54, Issue 11, pp. 2531-2533

DOI: 10.3109/10428194.2013.798868

Field-Weighted Citation Impact: 8.87